Human papillomavirus 16 integration and risk factors associated in anal samples of HIV-1 infected men

Sexually Transmitted Diseases

Volumn 37, Issue 5, 2010, Pages 311-315

  Cañadas, María Paz ^a,b   Darwich, Laila ^a,c   Sirera, Guillermo ^d,e   Bofill, Margarita ^a,d   Piñol, Marta ^d   Garcia Cuyas, Francesc ^d   Llatjos, Mariona ^d   Corbasi, Patricia ^e   Clotet, Bonaventura ^a,d,e   Videla, Sebastián ^e  

^a IrsiCaixa Foundation   (Spain)

^b General Lab   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^e Lluita Contra la SIDA Foundation   (Spain)

Author keywords

Anal cytology; HIV men; HPV infection; HPV 16 integration; Human papillomavirus

Indexed keywords

ADULT; ANUS; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CROSS-SECTIONAL STUDY; CYTOLOGY; DISEASE ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 16; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRECANCER; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; UTERINE CERVIX CANCER; VIRUS DNA CELL DNA INTERACTION; VIRUS INFECTION; WART VIRUS;

ADULT; ANAL CANAL; CROSS-SECTIONAL STUDIES; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; PREVALENCE; RISK FACTORS; RNA, VIRAL; SPAIN; VIRUS INTEGRATION; YOUNG ADULT;

EID: 77951691623     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3181c9c23f     Document Type: Article

References (19)

1. Castellsague X, Díaz M, de Sanjose S, et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its co-factors: Implications for screening and prevention. J Natl Cancer Inst 2006; 98:292-293.
2. Clifford GM, Smith JS, Plummer M, et al. Human papillomavirus types in invasive cervical cancer worldwide: A meta-analysis. Br J Cancer 2003; 88:63-73.
3. Cameron JE, Hagensee ME. Human papillomavirus infection and disease in the HIV+ individual. Cancer Treat Res 2007; 133: 185-213.
4. Pett M, Coleman N. Integration of high-risk human papillomavirus: A key event in cervical carcinogenesis? J Pathol 2007; 212:356-367.
5. Schiffman M. Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing. Cancer 2007; 111: 145-153.
6. Andersson S, Safari H, Mints M, et al. Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN). Br J Cancer 2005; 92: 2195-2200.
7. Jeon S, Allen-Hoffmann B, Lambert P. Integration of Human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: Implications for cervical carcinogenesis. Proc NatlAcad Sci 1995; 92:1654-1658.
8. Romanczuk H, Howley P. Disruption of either the E1 and E2 regulatory gene of human papillomavirus type 16 increases viral immortality capacity. Proc NatlAcad Sci 1992; 89:3159-3163.
9. Meissner JD. Nucleotide sequences and further characterization of human papillomavirus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell lines J Gen Virol 1999; 80:1725-1733.
10. Cañadas MP, Darwich L, Sirera G, et al. New molecular method for the detection of human papillomavirus type 16 integration. Clin Microbiol Infect. In press.
11. Vinokurova S, Wentzensen N, Kraus I, et al. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. Cancer Res 2008; 68:307-313.
12. Orlando G, Tanzi E, Beretta R, et al. Human papillomavirus genotypes and anal-related lesions among HIV-1-infected men in Milan, Italy JAIDS 2008; 47:129-131.
13. Gagne SE, Jensen R, Polvi, et al. High-resolution analysis of genomic alterations and human papillomavirus integration in anal intraepithelial neoplasia. J Acquir Immun Defic Syndr 2005; 40:182-189.
14. Critchlow CW, Holmes KK, Wood R, et al. Association of human immunodeficiency virus and anal human papillomavirus infection among homosexual men. Arch Intern Med 1992; 152:1673-1676.
15. Sirera G, Videla S, Pinol M, et al. High prevalence of human papillomavirus infection in the anus, penis and mouth in HIV-positive men. AIDS 2006; 20:1201-1204.
16. Palefsky JM, Holly EA, Ralston ML, et al. Prevalence and risk factors of human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis 1998; 177:361-367.
17. Strickler HD, Burk RD, Fazzari M, et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst 2005; 97:577-586. (Pubitemid 40723785)
18. Palefsky JM, Holly EA, Efirdc JT, et al. Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS 2005; 19:1407-1414.
19. Palefsky JM, Holly EA, Ralstan ML, et al. Effect of highly active antiretroviral therapy on the natural history of anal squamous intraepithelial lesions and anal human papillomavirus infection. Acquir Immune Defic Syndr 2001; 28:422-428.